Evonetix
PrivateLast Round
Series B
Extension
Feb 7, 2023
Est. Valuation
$108.16M
Total Funding Raised
$68.05M
Company Overview
Evonetix operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series B Extension round in February 2023.
Evonetix is a biotechnology company that develops DNA synthesis technology utilizing a specialized electronic silicon chip approach to produce high-fidelity genetic material.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Semiconductors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evonetix Comparables
Compare Evonetix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNA Script | 83% | |
| Switchback Systems | 83% | |
| Telesis Bio | 80% |
For institutional investors. Book with your work email.
Evonetix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 7, 2023 | ||||
| Series B | Mar 2, 2020 | ||||
| Grant | Jul 2, 2018 | ||||
| Series A | Jan 30, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evonetix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rising Tide Fund | Series A, Series B |
| Innovate UK | Grant |
| Providence Equity Partners | Series B |
| UK government | Grant |
| Morningside Ventures | Series A, Series B |
| Innovate UK | Grant |
| Foresite Capital | Series B Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2020
$30M round led by Foresite Capital
- Jul 2, 2018
Secured $1.75M from Innovate UK and the UK government.
For institutional investors. Book with your work email.
Evonetix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evonetix's valuation, stock price, and market status.
Is Evonetix a public or private company?
Evonetix is a private company.
What is the current stock price of Evonetix?
Evonetix is a private company, so its shares have no public market price. Caplight tracks Evonetix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evonetix worth (valuation)?
Evonetix's valuation is estimated at $108.2M based on funding round data.
Can I buy Evonetix stock?
Evonetix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evonetix's last funding round?
Evonetix's most recent funding round was Series B Extension on February 7, 2023.
Who are the main investors in Evonetix?
Key investors in Evonetix include Foresite Capital, Molten Ventures, DCVC (Data Collective).
Will Evonetix IPO soon?
No public IPO plans have been announced for Evonetix.
How can I track Evonetix secondary market activity?
Caplight tracks bids, offers, and trades in Evonetix's shares on secondary markets.